Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0608 | 0.1356 | 0.2235 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0043 | 0.0081 | 0.043 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0082 | 0.0171 | 0.5 |
Schistosoma mansoni | protein kinase | 0.0082 | 0.0171 | 0.0171 |
Giardia lamblia | hypothetical protein | 0.0235 | 0.0514 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0082 | 0.0171 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0043 | 0.0081 | 0.043 |
Echinococcus granulosus | aurora kinase A | 0.0082 | 0.0171 | 0.0908 |
Trypanosoma brucei | cAMP phosphodiesterase A, putative | 0.0235 | 0.0514 | 0.1436 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Toxoplasma gondii | hypothetical protein | 0.0608 | 0.1356 | 1 |
Leishmania major | hypothetical protein, conserved | 0.1591 | 0.3574 | 1 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.2727 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.0514 | 0.0513 |
Schistosoma mansoni | camp-specific cyclic nucleotide phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0123 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0082 | 0.0171 | 0.017 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase T04D3.3, putative | 0.0235 | 0.0514 | 0.0513 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trypanosoma brucei | GAF domain/TIP41-like family, putative | 0.1591 | 0.3574 | 1 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0043 | 0.0081 | 0.043 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trichomonas vaginalis | cGMP-inhibited 3,5-cyclic phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Echinococcus multilocularis | dual 3',5' cyclic AMP and GMP phosphodiesterase | 0.0842 | 0.1886 | 1 |
Echinococcus multilocularis | aurora kinase A | 0.0082 | 0.0171 | 0.0908 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0082 | 0.0171 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Trypanosoma cruzi | GAF domain/TIP41-like family, putative | 0.1591 | 0.3574 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0008 | 0.0004 | 0.0019 |
Brugia malayi | serine/threonine kinase 12 | 0.0082 | 0.0171 | 0.017 |
Plasmodium falciparum | 3',5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.2894 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trichomonas vaginalis | cGMP-inhibited 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trypanosoma brucei | 3', 5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Plasmodium falciparum | cGMP-specific phosphodiesterase | 0.0235 | 0.0514 | 0.2894 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0152 | 0.0329 | 0.0328 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0842 | 0.1886 | 0.5275 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Echinococcus granulosus | cpg binding protein | 0.0028 | 0.0049 | 0.0258 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Plasmodium falciparum | 3',5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.2894 |
Plasmodium vivax | phosphodiesterase gamma, putative | 0.0235 | 0.0514 | 0.2894 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trypanosoma cruzi | GAF domain/TIP41-like family, putative | 0.1591 | 0.3574 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0123 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0082 | 0.0171 | 0.5 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Brugia malayi | Protein kinase domain containing protein | 0.0152 | 0.0329 | 0.0328 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Trichomonas vaginalis | cAMP and cAMP-inhibited cGMP 3,5-cyclic phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Leishmania major | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0247 |
Giardia lamblia | Hypothetical protein | 0.0235 | 0.0514 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.0081 | 0.0081 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.09 |
Echinococcus granulosus | dual 3'5' cyclic AMP and GMP phosphodiesterase | 0.0842 | 0.1886 | 1 |
Echinococcus granulosus | high affinity cAMP specific 3'5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Echinococcus multilocularis | high affinity cAMP specific 3',5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Onchocerca volvulus | 0.0027 | 0.0045 | 0.5 | |
Brugia malayi | Cytochrome P450 family protein | 0.0025 | 0.004 | 0.0039 |
Schistosoma mansoni | calcium/calmodulin-dependent 35-cyclic nucleotide phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Plasmodium falciparum | cGMP-specific phosphodiesterase | 0.0235 | 0.0514 | 0.2894 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0025 | 0.004 | 0.011 |
Trypanosoma brucei | 3', 5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Entamoeba histolytica | protein kinase , putative | 0.0082 | 0.0171 | 0.5 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0025 | 0.004 | 0.008 |
Mycobacterium ulcerans | two component sensor histidine kinase DevS | 0.2199 | 0.4945 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0043 | 0.0081 | 0.008 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0008 | 0.0004 | 0.0019 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0235 | 0.0514 | 0.0647 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0051 | 0.0099 | 0.0725 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trypanosoma brucei | aurora B kinase | 0.0082 | 0.0171 | 0.0476 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.0081 | 0.0081 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.0235 | 0.0514 | 0.0513 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0247 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.1591 | 0.3574 | 0.7226 |
Trypanosoma cruzi | cAMP phosphodiesterase A, putative | 0.0235 | 0.0514 | 0.1436 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Giardia lamblia | CAMP-specific 3,5-cyclic phosphodiesterase 4B | 0.0235 | 0.0514 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0082 | 0.0171 | 0.017 |
Trypanosoma brucei | cAMP-specific phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Plasmodium falciparum | GAF domain-related protein, putative | 0.0608 | 0.1356 | 1 |
Plasmodium falciparum | phosphodiesterase delta, putative | 0.0235 | 0.0514 | 0.2894 |
Entamoeba histolytica | protein kinase, putative | 0.0082 | 0.0171 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0235 | 0.0514 | 0.0647 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.2727 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0027 | 0.0045 | 0.0044 |
Trypanosoma cruzi | cyclic nucleotide phosphodiesterase | 0.0235 | 0.0514 | 0.1436 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Echinococcus granulosus | high affinity cgmp specific 3' 5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.0842 | 0.1886 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0082 | 0.0171 | 0.017 |
Leishmania major | cAMP phosphodiesterase A, putative;with=GeneDB:LinJ18_V3.1100 | 0.0235 | 0.0514 | 0.1436 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0061 | 0.0123 | 0.0652 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0082 | 0.0171 | 0.017 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Trichomonas vaginalis | cAMP and cAMP-inhibited cGMP 3,5-cyclic phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Leishmania major | protein kinase, putative | 0.0082 | 0.0171 | 0.0476 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0025 | 0.004 | 0.0039 |
Trypanosoma brucei | cytochrome P450, putative | 0.0025 | 0.004 | 0.011 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Plasmodium vivax | 3',5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.2894 |
Echinococcus multilocularis | high affinity cgmp specific 3' 5' cyclic | 0.0235 | 0.0514 | 0.2727 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0025 | 0.004 | 0.0039 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0057 | 0.0113 | 0.0113 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Plasmodium vivax | 3',5'-cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.2894 |
Echinococcus multilocularis | 0.0007 | 0.0001 | 0.0005 | |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0007 | 0.0001 | 0.0005 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Leishmania major | cytochrome p450-like protein | 0.0025 | 0.004 | 0.011 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0608 | 0.1356 | 0.2235 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0608 | 0.1356 | 0.2235 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0049 | 0.0049 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0608 | 0.1356 | 0.2235 |
Mycobacterium ulcerans | putative regulatory protein | 0.0608 | 0.1356 | 0.2741 |
Plasmodium vivax | hypothetical protein, conserved | 0.0608 | 0.1356 | 1 |
Trypanosoma cruzi | cAMP phosphodiesterase A, putative | 0.0235 | 0.0514 | 0.1436 |
Plasmodium vivax | cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.2894 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0082 | 0.0171 | 0.0908 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.2433 | 0.5475 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0007 | 0.0001 | 0.0001 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase R153.1, putative | 0.0235 | 0.0514 | 0.0513 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0842 | 0.1886 | 0.5275 |
Plasmodium falciparum | phosphodiesterase gamma, putative | 0.0235 | 0.0514 | 0.2894 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0049 | 0.0049 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Loa Loa (eye worm) | hypothetical protein | 0.0608 | 0.1356 | 0.1356 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0025 | 0.004 | 0.0039 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0842 | 0.1886 | 0.5275 |
Loa Loa (eye worm) | hypothetical protein | 0.4439 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Toxoplasma gondii | GAF domain-containing protein | 0.0608 | 0.1356 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Brugia malayi | Cytochrome P450 family protein | 0.0025 | 0.004 | 0.0039 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Toxoplasma gondii | aurora kinase | 0.0082 | 0.0171 | 0.1256 |
Schistosoma mansoni | camp/cgmp cyclic nucleotide phosphodiesterase | 0.0842 | 0.1886 | 0.1886 |
Mycobacterium leprae | conserved hypothetical protein | 0.0608 | 0.1356 | 1 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.0842 | 0.1886 | 1 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Toxoplasma gondii | hypothetical protein | 0.0608 | 0.1356 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0024 | 0.0023 |
Schistosoma mansoni | TPX2 protein | 0.0106 | 0.0224 | 0.0224 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Schistosoma mansoni | cytochrome P450 | 0.0007 | 0.0001 | 0.0001 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.1825 | 0.4103 | 0.7414 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0043 | 0.0081 | 0.043 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.2727 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0842 | 0.1886 | 0.5275 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative | 0.0842 | 0.1886 | 0.1885 |
Trypanosoma cruzi | cAMP-specific phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Loa Loa (eye worm) | calcium/calmodulin-stimulated cyclic nucleotide phosphodiesterase | 0.0235 | 0.0514 | 0.0513 |
Entamoeba histolytica | protein kinase, putative | 0.0082 | 0.0171 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0027 | 0.0045 | 0.0045 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.0235 | 0.0514 | 0.0513 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Loa Loa (eye worm) | AUR protein kinase | 0.0082 | 0.0171 | 0.017 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0061 | 0.0123 | 0.0342 |
Echinococcus multilocularis | cpg binding protein | 0.0028 | 0.0049 | 0.0258 |
Loa Loa (eye worm) | histone methyltransferase | 0.0008 | 0.0004 | 0.0003 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0061 | 0.0123 | 0.0652 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0247 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.2727 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0123 | 0.0247 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Leishmania major | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Leishmania major | cAMP-specific phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Brugia malayi | CXXC zinc finger family protein | 0.0027 | 0.0045 | 0.0044 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0025 | 0.004 | 0.011 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0152 | 0.0329 | 0.0329 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.1825 | 0.4103 | 0.7414 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0235 | 0.0514 | 0.3787 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0235 | 0.0514 | 0.1436 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0235 | 0.0514 | 0.0514 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0043 | 0.0081 | 0.008 |
Toxoplasma gondii | hypothetical protein | 0.0608 | 0.1356 | 1 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0082 | 0.0171 | 0.0476 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2433 | 0.5475 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.0081 | 0.0081 |
Schistosoma mansoni | cgmp-dependent 35-cyclic phosphodiesterase | 0.4439 | 1 | 1 |
Mycobacterium tuberculosis | Two component sensor histidine kinase DevS | 0.2199 | 0.4945 | 1 |
Trichomonas vaginalis | cAMP/cGMP cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Loa Loa (eye worm) | PDE1B protein | 0.0235 | 0.0514 | 0.0513 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.2433 | 0.5475 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.0514 | 0.0513 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0082 | 0.0171 | 0.0908 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Mycobacterium tuberculosis | Two component sensor histidine kinase DosT | 0.0608 | 0.1356 | 0.2741 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0235 | 0.0514 | 0.1436 |
Mycobacterium ulcerans | putative regulatory protein | 0.0608 | 0.1356 | 0.2741 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0235 | 0.0514 | 0.0647 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0008 | 0.0003 | 0.0002 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0082 | 0.0171 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.0514 | 0.0513 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0842 | 0.1886 | 0.5275 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0842 | 0.1886 | 0.3233 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.2433 | 0.5475 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.85 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.717 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.717 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.676 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.674 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.647 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.646 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.637 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.614 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.265 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.